Breaking News

FUJIFILM Corporation Invests $1.2B in Holly Springs, NC Facility

Aims to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility.

Author Image

By: Charlie Sternberg

Associate Editor

FUJIFILM Corporation has invested $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. About the Planned Expansion The expansion adds significant large-scale production capacity to FUJIFILM Diosynth Biotechnologies’ global network through its United States and Europe manufacturing hub...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters